Stay informed on the novel Coronavirus (Covid-19)

Keep abreast of coronavirus and its ongoing impact on markets and the economy. The situation remains fluid, so we plan to update this page regularly.

Featured Content

Signs of Stability?

Signs of Stability?

Does recent economic data point to stabilization? Will debt overhang lead to downgrades? When will the bill for the policy wave come due? Chief US Economist Eric Winograd answers your questions.

View Video »

AB Bernstein Head David Barnard

Our Commitment to You Amid Covid-19

Amidst an unprecedented level of uncertainty and anxiety, Bernstein Head David Barnard reaffirms our commitment to serving you.

View Video »

Negative US Rates

The Market and Negative US Rates

The Fed shot down the notion of negative US interest rates last week—again. Yet the market continues to stubbornly price them in. This is a mistake, right? Probably, but the thought process behind this behavior is actually sound.

Read Blog »

Timely Questions

Our investment professionals respond to the most frequently asked questions we’re hearing right now.

Can Too Much of a Single Stock Be a Bad Thing?

When times are good, concentrated stock positions look limitlessly profitable. But what happens in a reversal?

Read More »

Can Illiquidity Work to Private Investors’ Advantage?

In private markets, which are typically illiquid, investment results are less influenced by market gyrations. That’s a singular advantage.

Read More »

Should You Revisit Your Estate Plan?

Being the loved one left behind is incredibly difficult. The steps you take in advance can help ease the pain.

Read More »

Will We See a Wave of Corporate Bond Defaults?

Corporate bond defaults will likely spike, but today’s yields will more than compensate investors for potential losses.

Read More »

Keeping in Touch

Navigate a Viral Crisis

Ugly Employment Report Underscores Virus' Impact

Today’s employment report once again shed a light on the historically unprecedented impact of the coronavirus shock. Yet that doesn’t seem to matter for the market, which is looking forward and beginning to build a bridge to a more normalized 2021

Continue Reading » Archive »

Gaining Industry Perspectives

Promising Paths to Treat Covid-19

Promising Paths to Treat Covid-19

With over 50 credible efforts underway to develop drugs, antibodies, and vaccines, the outlook for treatment is looking up. Ronny Gal—Bernstein’s senior research for Global Biotechnology and Pharmaceuticals—shares his prognosis.

Listen to Podcast »

Widening the Lens

Blue Ribbon

Election Time: Which Are the Best Candidates…for Wealth Transfer?

Now is the ideal time to shift assets for the benefit of generations to come. But which investments might make truly spectacular wealth transfer candidates?

Download PDF »

The information presented and opinions expressed are solely the views of the authors. AllianceBernstein L.P. or its affiliates makes no representations or warranties concerning the accuracy of any data. There is no guarantee that any projection, forecast or opinion in this material will be realized. Past performance does not guarantee future results. The views expressed here may change at any time after the date of this material. This is for informational purposes only and does not constitute investment advice. AllianceBernstein L.P. does not provide tax, legal or accounting advice. It does not take an investor’s personal investment objectives or financial situation into account; investors should discuss their individual circumstances with appropriate professionals before making any decisions. This information should not be construed as sales or marketing material or an offer or solicitation for the purchase or sale of any financial instrument, product or service sponsored by AllianceBernstein or its affiliates. The [A/B] logo is a registered service mark of AllianceBernstein, and AllianceBernstein® is a registered service mark, used by permission of the owner, AllianceBernstein L.P.

© 2020 AllianceBernstein L.P.